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The ab T cell antigen receptor (TCR), in complex
with the CD3d3, g3, and zz signaling subunits, is
the chief determinant for specific CD4+ and
CD8+ T cell responses to self and foreign anti-
gens. Although transmembrane domain charge
interactions are critical for the assembly of the
complex, the location of extracellular contacts
between the TCR and CD3 subunits and their
contributions to stability and signal transduc-
tion have not been defined. Here we usedmuta-
genesis to demonstrate that the CD3d3 and
CD3g3 subunits interact with the TCR via adja-
cent Ca DE and Cb CC0 loops, respectively.
The TCR-CD3d3 interactions helped stabilize
CD3g3 within the complex and were important
for normal T cell and thymocyte responses to
TCR engagement. These data demonstrate
that extracellular TCR-CD3 subunit interactions
contribute to the structural integrity and func-
tion of this multisubunit receptor.
INTRODUCTION
Most T cell antigen receptors (TCRs) expressed on CD4+
or CD8+ T cells are disulfide-bonded heterodimers, com-
prised of TCRa and TCRb subunits, which recognize pep-
tide antigens bound to major histocompatibility complex
molecules (pMHC) (Rudolph et al., 2006). Both TCR sub-
units have extracellular variable regions for binding anti-
gen that are encoded by clonotypically rearranged V, (D),
and J gene segments (Davis et al., 1998). Conserved con-
stant region gene segments encode the extracellular con-
stant regions, connecting peptides, transmembrane re-
gions, and intracellular regions of both subunits. abTCRs
cannot reach the cell surface to engage pMHC unless
they are assembled into a complex with the CD3g3, d3,
and zz dimers (Call and Wucherpfennig, 2005; Delgado
and Alarcon, 2005; Morley et al., 1988; Wegener et al.,
1995), which are necessary for signal transduction. The
TCR has a short intracellular sequence with no known
signaling capacity, whereas the CD3-signaling subunitscontain immunoreceptor tyrosine-based activation motifs
(ITAMs) that couple the abTCR to the signal-transduction
machinery (Kane et al., 2000). This signaling complex is
extremely sensitive to low-affinity ligands. It mediates
positive and negative selection of thymocytes on self-
pMHC (Starr et al., 2003). In addition, for mature T cells,
it can trigger a range of cellular responses that reflect
the biophysical properties of the TCRpMHC interactions
(Davis et al., 1998; Krogsgaard et al., 2003) and can
even initiate signaling when only a single agonist pMHC
is present on antigen-presenting cell (APC) (Irvine et al.,
2002). Still, it is unknown how information about TCR
engagement is relayed to the CD3 subunits for transmis-
sion to the intracellular signaling machinery.
The intersubunit contacts and overall organization of the
complex are thought to be important for the earliest events
in TCR-CD3 signaling (reviewed in Kuhns et al., 2006).
However, determining the complete structure of this com-
plex represents a formidable challenge. Thus, investiga-
tors have turned to other means to infer the pairing and
organization of the subunitswithin the different domain en-
vironments. Mutagenesis of the TCR and/or CD3 subunits
by truncation (Manolios et al., 1990, 1994), by domain
swapping (Delgado and Alarcon, 2005; Manolios et al.,
1990, 1994; Wegener et al., 1995), or by site-specific
changes of one ormore of the residueswithin a specific re-
gion (Call et al., 2002; Delgado and Alarcon, 2005; Morley
et al., 1988; Sun et al., 2001; Xu et al., 2006) has provided
some of the clearest insights into the interactions and
organization of the subunits. The pairing, stoichiometry,
and general organization of the transmembrane regions
of the complex are delineated by highly conserved charge
interactions that occur at the interface of the transmem-
brane helices between TCRa with CD3d3 and CD3zz, as
well as TCRb with CD3g3 (Call et al., 2002; Call and
Wucherpfennig, 2005). The stalk regions that connect
the TCR, CD3d3, and CD3g3 heterodimers to the mem-
brane have also been implicated in complex assembly
(Xu et al., 2006). Yet, the extracellular organization of the
TCR and CD3 heterodimers, the contacts that stabilize
this organization, and the role of these contacts in TCR-
CD3 signaling are poorly understood (Kuhns et al., 2006).
In the present study, site-specific mutagenesis of the
TCR was employed to identify regions of the TCR Ca
and Cb domains that may interact with CD3d3 or CD3g3Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc. 357
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TCR-CD3 Interactions at the Ca DE and Cb CC0 LoopsFigure 1. TCR Ca Regions Targeted for Mutagenesis
(A) Locations within the tertiary structure. A cartoon of the murine 2C TCR (Garcia et al., 1996) is shown with TCRa in white and TCRb in magenta. The
variable (V) and constant (C) regions are indicated, and the targeted regions are highlighted: AB loop (green), C strand (yellow), DE loop (cyan), and
F strand (red). The Cb FG loop is indicated by an asterisk. All structural figures were generated with PyMol (PyMol Molecular Graphics System).
(B) Primary mammalian sequence comparisons. Residues targeted for mutagenesis are colored as follows: acidic (red), basic (blue), aromatic res-
idues (cyan), remaining polar residues (green), remaining hydrophobic residues (gray). Black residues are considered to be significant to the tertiary
structure. The consensus N-linked glycosylation sites (NXT/S) are indicated with asterisks for the F strand. The human C strand has a glycosylation
site that is not conserved in the mouse sequence. The mutations introduced at each targeted region are shown. Alignments were performed with
TBLASTN (Altschul et al., 1997).and facilitate the transfer of information from the
TCRpMHC binding interface to the signal transduction
machinery. We report that the Ca DE loop mediates inter-
actions with CD3d3, whereas association of CD3g3 with
the TCR requires the adjacent Cb CC0 loop and interac-
tions between CD3d3 and the DE loop. T cell and thymo-
cyte responses to pMHC are altered by these DE loopmu-
tants, indicating that normal TCR signaling is influenced
by extracellular TCR-CD3 interactions.
RESULTS
Candidate Sites for CD3 Subunit Interaction with Ca
In order to probe for specific interactions between the
abTCR and CD3 heterodimers, we initially focused on
the mouse Ca AB loop, C strand, DE loop, and F strand
(Figure 1). These regions were chosen after reviewing
the literature for proposed CD3 heterodimer docking sites
(Kuhns et al., 2006), comparing themouse sequences with
other mammalian species to identify evolutionarily con-
served solvent-accessible residues that may be critical
for abTCR function, and by inspection of these regions
within the tertiary structure of the abTCR.
The AB loop contains a positive-charged residue, R134,
in the mouse sequence and projects into a cavity of the358 Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc.Cb domain that has been proposed to serve as a docking
site for the electronegative CD33 subunit of CD3g3
(Ghendler et al., 1998; Kjer-Nielsen et al., 2003; Wang
et al., 1998). The highly polar C and F strands constitute
one face of the Ca domain. Both form weak interactions
with the bottom sheet, suggesting a mobility that may
allow interactions with the CD3 heterodimers (Garcia
et al., 1996). The C strand has a highly conserved nega-
tive charged residue, D147, in mouse, and the F strand
has conserved N-linked glycosylation sites. The DE
loop is situated in a proposed docking site for one of
the CD3 heterodimers based on electrostatic analysis
of the human TCR (Kjer-Nielsen et al., 2002), wrapping
across the interface between the Ca and Cb near the
a hinge. It has a conserved motif consisting of a positive
charge at murine position 171, a hydrophobic residue at
position 173, and a negatively charged residue at posi-
tion 174, which suggests that this region may have func-
tional significance (Figure 1B). Finally, the DE loop and
the F strand contain sequences that form part of the
epitope for the H28 antibody, which binds mouse
TCRa only in the absence of the CD3 molecules (Karai-
vanova et al., 1999). Thus, one of the CD3 heterodimers
might directly contact or be in proximity to one of these
regions.
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TCR-CD3 Interactions at the Ca DE and Cb CC0 LoopsFigure 2. The Ca DE Loop Interacts with CD3d3
(A) The Camutations do not impair TCR surface expression. TCR-CD3 expression on M12 cells was assessed with anti-Vb3 as described in Exper-
imental Procedures. Histograms represent 1 3 104 events.
(B) The Ca DE loop mediates TCR-CD3d3 interactions. Anti-Va11 TCR cell-surface immunoprecipitation and western blotting of coprecipitated
proteins were performed as described in Experimental Procedures. Lysates from 5 3 106 cells were loaded in each lane.
(C–F) Concomitant binding of monoclonal antibodies to two distinct epitopes stabilizes DE mutant complexes. Anti-CD33 (2C11) (C and D) or anti-
Va11 (E and F) surface immunoprecipitations ± H57 pretreatment and western blots were performed as described in Experimental Procedures.
Lysates from 3 3 106 cells were loaded per well.
(D and F) The ratio of CD3d to CD3g signal intensity was measured as described in Experimental Procedures. The ratios are presented as the percent
of the control sample in the absence of H57. The data represent the average of three experiments ± standard error.Mutagenesis
The 2B4 TCRwas used for this study (Hedrick et al., 1982).
It recognizes amoth cytochrome-c-derived peptide (MCC
88–103) bound to themouse class II MHC I-Ek, and utilizes
the Va11 and Vb3 TCR gene segments (Davis et al., 1998).
Mutagenesis was designed to disrupt the chemical nature
of the solvent-accessible region of interest by altering the
size, hydrophobicity, charge, or glycosylation state of the
targeted residues without altering the hydrophobic core
residues that stabilize the protein. All of the Ca mutants
tested here are shown in Figure 1B.
To generate these mutations, unique restriction enzyme
sites were introduced throughout the gene segment en-
coding the Ca domain. Mini-genes encoding the mutant
target regions were then subcloned into these sites. The
majority of the restriction-site mutations were silent, but
one changed a serine to threonine at position 208 in the
G strand and was subsequently present in all mutant
TCRs. The TCR bearing only the S208T mutation was
designated aWT0.TCR-CD3 Reconstitution
The extracellular domains of the TCR and CD3 hetero-
dimers do not interact in solution (Sun et al., 2004; K.C.
Garcia, personal communication), suggesting that such
interactions may be weak and/or require the transmem-
brane domains or the membrane environment to facilitate
their formation. Thus, TCR-CD3 expression was reconsti-
tuted in the B cell lymphoma M12 in order to study full-
length TCR and CD3 subunits assembled in the mem-
brane environment without endogenous subunits being
present. By monitoring cell-surface expression, we could
employ the cells’ quality control machinery to determine
whether themutations inhibited protein folding or complex
assembly and transport (Trombetta and Parodi, 2003).
All of the TCRamutants described here were capable of
surface expression with TCRb (Figure 2A). Some variabil-
ity was observed in expression between independent lines
expressing different (Figure 2A) or identical (not shown)
TCRs, as is expected when using outgrown lines that are
likely to contain different copy numbers of the constructs.Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc. 359
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TCR-CD3 Interactions at the Ca DE and Cb CC0 LoopsThe data indicate that the mutations do not markedly hin-
der protein folding, complex assembly, or transport.
TCR-CD3 Analysis
After we established a system in which the wild-type and
mutant TCRs could be assembled and expressed in a
membrane environment, an assay was needed for deter-
mining whether themutant TCR-CD3 heterodimer interac-
tions are diminished compared with the controls. We took
advantage of the observation that the mouse abTCR-CD3
complex stays intact, but the human complex dissociates,
in the detergent NP-40 (Lew et al., 1987). The TCR trans-
membrane charged residues are conserved between
mouse and man (Call et al., 2002; Manolios et al., 1991),
indicating that NP-40 disrupts these interactions enough
to allow the human complex to dissociate. We hypothe-
sized that the difference in integrity in NP-40 between
the two species may be due to stronger extracellular inter-
actions in the mouse. Thus, solubilization and coassocia-
tion studies in NP-40 might reveal disruptions of weak
extracellular interactions resulting from mutagenesis.
Analysis of folded, assembled, and cell surface-local-
ized complexes was important to minimize background
from unassembled or partially assembled subunits. Cells
were surface labeled with monoclonal antibodies (mAbs)
against the proteins of interest and then washed to re-
move unbound mAbs prior to lysis and immunoprecipita-
tion. Lysis was performed with the NP-40 analog IGEPAL
CA-630. Specific immunoprecipitations of cell-surface
TCR and CD3 heterodimers were verified with anti-H2-
Kd, Va11, and CD33 via cell lines expressing surface
TCR-CD3 complexes or intracellular, but not surface, CD3
heterodimers (see Figure S1 in the Supplemental Data
available online). Immunoprecipitations of cell-surface
TCR with anti-Va11 coprecipitated the disulfide-bonded
TCRb from all lines (Figure 2B), which serves as an indica-
tor of the amount of precipitated TCR.
The Ca DE Loop Stabilizes CD3d3 within
the TCR-CD3 Complex
In cells expressing the aWT and aWT0 TCRs, immunopre-
cipitation with anti-Va11 coprecipitated CD3d and CD3g
equivalently (Figure 2B and Figure S2). Thus, the S208T
substitution does not impact TCR interactions with the
CD3 heterodimers. In contrast, the DE loop mutant TCRs
coprecipitated much less CD3d compared with CD3g
(Figure 2B and Figure S2). Comparison of Vb3 coexpres-
sion with Va11 or CD33 by flow cytometry showed that
the codependent, proportional relationship of expression
between TCRa and b, or TCR and CD33, were not disrup-
ted by the DE loop mutations (Figure S3). Immunoprecip-
itation with anti-CD33 coprecipitated CD3d from the sur-
face of the control and DE loop mutant M12 cells
(Figure 2C, lanes 1, 3, and 5). Thus, CD3d3 is present on
the cell surface and dissociates from the DE loop mutant
TCRs under these experimental conditions. These data
suggest that the Ca DE loop is a component of the
CD3d3 docking site on the TCR.360 Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc.Cobinding of Anti-TCRb and CD33 Stabilizes DE
Loop Mutant Complexes
CD3g3 is thought to dock with the TCR in a pocket con-
taining the Ca AB loop that is bordered by the Cb FG
loop and the Ca CD and EF loops (Ghendler et al., 1998;
Kjer-Nielsen et al., 2003; Wang et al., 1998). However,
the AB1 and AB2 mutants, the C1 mutant that includes
mutated residues of the CD loop, and the F1 and F8 mu-
tants that include mutated N-linked glycosylation motifs
of the EF loop did not impact association of CD3g3 with
the TCR (Figure 2B). These results do not support a role
for any of the solvent-accessible residues in these regions
in interacting with CD3g3.
The data supporting the above-mentioned pocket as a
CD3g3 docking site comes primarily from the finding that
prestaining T cells with the mAb H57, which binds the
Cb FG loop, results in reduced staining with mAb 2C11,
which binds an unknown epitope on CD33 (Ghendler
et al., 1998). H57 is thought to sterically hinder 2C11 bind-
ing, placing it in close proximity to one of the CD33 epi-
topes. Because the DE loop mutant TCR-CD3 complexes
dissociated into CD3d3 and TCR-CD3g3 in our experi-
ments, if H57 directly inhibits 2C11 binding to CD3g3,
then TCR-CD3g3 should be underrepresented in a
2C11-immunoprecipitation of DE mutant TCRs after H57
pretreatment compared with a nontreated sample (Fig-
ure S4). The previous antibody mapping results were ver-
ified by flow cytometry for the control, DE1, and DE2 M12
lines (Table S1), indicating that H57 inhibits 2C11 staining
on TCR+ M12 cells.
As discussed above, surface immunoprecipitations
with 2C11, but without H57 pretreatment, coprecipitated
CD3d from the control and both DE mutants (Figure 2C,
lanes 1, 3, and 5). Interestingly, less TCRb coprecipitated
with 2C11 from the DE mutants compared with the
control. This confirms that the DE1 and DE2 mutations
weaken the extracellular interactions necessary to copre-
cipitate the entire complex. But, contrary to the predicted
result, 2C11 did not efficiently immunoprecipitate the dis-
sociated TCR-CD3g3 subcomplex. Rather, 2C11 pulled
downmore CD3d thanCD3g from theDE lines, suggesting
that the dominant CD33 bound by 2C11 is the one paired
with CD3d. The 2C11 epitope on CD3g3 could be partially
masked by the TCR, CD3d3, or both, in the absence of H57
pretreatment. Alternatively, 2C11 may have a higher affin-
ity for CD33 when paired with CD3d over CD3g.
H57 pretreatment enhanced the coprecipitation of
CD3g and TCRb with CD33 in the DE mutant samples but
had no impact on the control samples (Figures 2C and
2D). Some TCR-specificmAbs can lead to TCR cocapping
(Kupfer and Singer, 1988), and two distinct mAbs binding
to distinct complex epitopes could lead to clustering of
the complexes, which might stabilize TCR-CD3d3 interac-
tions weakened by the DE loop mutations and increase
the efficiency with which all subunits are coprecipitated.
To test this further, immunoprecipitations were performed
with anti-Va11 ± H57 pretreatment (Figures 2E and 2F).
Consistent with this idea, pretreatment of DE1 and DE2
samples with H57 stabilized CD3d with the mutant TCRs
Immunity
TCR-CD3 Interactions at the Ca DE and Cb CC0 Loops(Figure 2C, lanes 4 and 6 versus 3 and 5), whereas the con-
trol TCR was unaffected (lanes 1 and 2). H57 alone did not
stabilize DE mutant complexes (Figure S5). These data
suggest that clustering of TCR-CD3 complex by two dis-
tinctmAbs can stabilizeweakenedTCR-CD3d interactions
caused by the DE1 and DE2mutations. The reduced 2C11
staining afterH57pretreatment, shownhere (TableS1) and
elsewhere (Ghendler et al., 1998), may be the result of
2C11 epitopes being masked by TCR-CD3 complex clus-
ters rather than, or in addition to, being sterically hindered
by H57. Importantly, these data do not allow us to identify
where CD3g3 interacts with the TCR.
The Cb CC0 Loop and TCR-CD3d3 Interactions
Stabilize CD3g3 in the Complex
Considerationwas also given to the hypothesis thatCD3g3
associates with the TCR in close proximity to the
CD3d3 docking site and that this arrangement stabilizes
CD3g3 within the complex (Kuhns et al., 2006). This hy-
pothesis is largely based upon the finding that TCR-
CD3d3 interactions occur at nearly normal levels in the
absence of CD3g3, but that optimal CD3g3 association
with the TCR requires the presence of CD3d3 (Call et al.,
2002). In support of this, we observed that the amount of
CD3g coprecipitating with the TCR appeared slightly re-
duced in the DEmutants compared to the control samples
(Figure S6). This difference suggests that CD3d3 interac-
tions with the DE loop might play a role in stabilizing
CD3g3 interactions with the TCR.
Previous findings suggest that the Cb domain is the
likely site for interactions with CD3g3. CD33 alone can in-
teract with TCRb at an unknown site in an extracellular
domain-dependent manner (Manolios et al., 1991), and
the extracellular domain of CD3g can be chemically cross-
linked to TCRb (Brenner et al., 1985; Koning et al., 1990).
We reviewed the literature, primary mammalian sequence
alignments, and Cb tertiary structure for a region that is in
close proximity to the Ca DE loop with similar characteris-
tics. The Cb CC0 loop (164–171) is adjacent to the Ca DE
loop (Figure 3A), and previous docking models have impli-
cated it as a part of a putative CD33 binding site (Sun et al.,
2001). In addition, there is nearly invariant conservation of
solvent-accessible residues at position 166 (lys) and 167
(glu or gln) (Figure 3B), suggesting functional importance.
Mutagenesis of this region was performed similarly to that
of the Ca domain, with the target residues being con-
verted to alanines (CC01) or altered in size and charge
(CC02), as shown in Figure 3B.
When expressed inM12 cells, the CC01mutant-contain-
ing TCRs failed to reach the surface (Figure 3C, Figure S1),
suggesting a problem with folding or complex assembly.
CC02 mutant TCRs did express on the cell surface, but
at reduced amounts compared with lines expressing the
wild-type TCRb (Figure 3C, Figure S1). These results
were observed with multiple CC02 expressing lines (Fig-
ure 3C), suggesting mutation-intrinsic defects in expres-
sion rather than a lower copy number of TCR or CD3
genes. Surface expression of the CC02 mutant TCRs sug-
gests that they pass the cells’ quality control machineryand do not markedly hinder protein folding, stability, or
complex assembly. However, the rate of these processes
could be slightly impaired.
Anti-Va11 immunoprecipitations were performed to de-
termine whether the association of the aWTbCC02 and
aWT0bCC02 TCRs with the CD3 heterodimers were less
stable than the controls. Samples were loaded based
upon previous calibration experiments (not shown) in an
effort to achieve equivalent amounts of the CD3 hetero-
dimers, because differences in loaded TCRs were easiest
to discriminate. Loading of less precipitated control
TCR (Figure 3D, lane 1) was required, compared to the
aWTbCC02 and aWT0bCC02 TCRs (lanes 2 and 6), to
achieve roughly equivalent amounts of coprecipitated
CD3d and CD3g. Thus, the CC02 mutations weaken the
association of both CD3 heterodimers (Figures 3D–3F).
These findings are consistent with the hypothesis that
CD3g3 interacts with the Cb CC0 loop. The failure of the
Cb CC02 mutant to have a phenotype for binding CD3g3
that is reciprocal to the Ca DE loop mutant phenotype for
interacting with CD3d3 is also consistent with the idea
that TCR-CD3d3 interactions help stabilize TCR-CD3g3 in-
teractions. To test this further, M12 lines expressing TCRs
mutated in both the Ca DE and Cb CC0 loops were gener-
ated. Ca DE1 or DE2 and Cb CC20 double mutant TCRs
should favor dissociation of both CD3 heterodimers from
the TCRwhen precipitated with anti-Va11. This is because
the DE loop mutations caused the dissociation of CD3d3
from the complex, and, in the absence of stabilizing
TCR-CD3d3 interactions, if the Cb CC0 loop is a docking
site for CD3g3, then mutagenesis of this loop should also
cause CD3g3 to dissociate from the TCR.
Very little CD3d and CD3g coprecipitated with the TCRs
from the DEbCC02 double mutants compared to the single
CC02 mutants or the control TCR (Figures 3D–3F). These
data demonstrate that extracellular association of CD3g3
with the TCR requires the Cb CC0 loop and CD3d3 interac-
tions with the Ca DE loop. Comparisons of the coexpres-
sion of TCRb with TCRa or CD33 by flow cytometry
indicate that these mutations did not disrupt the propor-
tional expression of these subunits at the cell surface (Fig-
ure S7), and immunoprecipitations with anti-CD33 con-
firmed that the CD3 heterodimers were present on the
cell surface (Figure 3D). We conclude from the sum of
these data that extracellular TCR-CD3g3 interactions re-
quire contacts at the Cb CC0 loop as well as TCR-CD3d3
interactions.
Function of Extracellular TCR-CD3 Contacts
After we identified mutants that disrupt TCR-CD3 interac-
tions, their function was assessed in T cells and thymo-
cytes. We focused on the DE loop because mutating the
CC0 loop impairs TCR-CD3 surface expression, and com-
parable expression is needed in order to compare cellular
responses to ligand.
To evaluate the importance of the Ca DE loop for T cell
signaling, control and DE1 2B4 TCRs were expressed
in the T helper 2 (Th2) CD4+ T cell line, D10 (Kaye et al.,
1983). Equivalent surface expression was observedImmunity 26, 357–369, March 2007 ª2007 Elsevier Inc. 361
Immunity
TCR-CD3 Interactions at the Ca DE and Cb CC0 LoopsFigure 3. TCR-CD3Complex Stability Requires Coordinated Interactions Involving the CD3Heterodimers, theCaDELoop, and the
Cb CC0 Loops
(A) The Cb CC0 loop is adjacent to the Ca DE loop. Cartoon representation of the murine TCR as in Figure 1A, with the Ca DE (cyan) and Cb CC0 loops
(orange) highlighted.
(B) Sequence analysis of the Cb CC0 loop as in Figure 1B. The CC01 and CC02 mutants are shown.
(C) Mutagenesis of the Cb CC0 loop impairs TCR-CD3 complex surface expression. TCR expression on M12 cells was performed as in Figure 2A.
(D–F) TCR-CD3g3 stability requires the Cb CC0 loop and TCR-CD3d3 interactions.
(D) Anti-Va11 (top) and anti-CD33 (bottom) immunoprecipitations and western blots were performed as described in Figure 2. Lysates from 2 3 106
cells were loaded for the control samples and 7 3 106 cells per lane for all CC02 samples.
(E and F) Signal intensities of TCRb, CD3d, and CD3gwere measured as in Figure 2 for the anti-Va11 immunoprecipitations experiments represented
in (D). The ratio of CD3d/TCRb (E) and CD3g/TCRb (F) are shown as a percent of the control TCR values. The bars for the aWTbCC02 and aWT0bCC02
samples represent the averages of seven separate experiments, while those for the DE1bCC02 and DE2bCC02 samples represent the averages of four
separate experiments ± standard error.between the control and DE1 lines, with some line-to-line
variability (Figure S8). The DE1 mutation diminished TCR-
CD3 complex stability. Interestingly, attempts to generate
DE2 mutant D10 lines failed, suggesting that this TCR
impairs T cell propagation.
The ability of the T cells to flux calcium in response to
antigen-presenting cells (APCs) pulsed with agonist ligand
was assessed as a measure of TCR signaling. A classic
calcium flux profile was observed for the aWT and aWT0
D10 lines after T cell:APC contact (Wu¨lfing et al., 1997):
an initial spike of calcium at 1–3min after contact resolved
into a plateau of sustained calcium (Figure 4). Deviation
among the individual cells bearing the control TCRs was
observed, with a large standard deviation for the aWT0
cells deriving mostly from outliers in line 2 (Figure S9 and
data not shown). The data indicate that the calcium fluxes
induced by the aWT and aWT0 TCRs are equivalent, with362 Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc.any variability being within the normal range for T cell lines
(Wu¨lfing et al., 1997).
In contrast, cells bearing the DE1 TCR lacked the initial
spike of intracellular calcium after APC contact (Figure 4).
A pronounced delay, with little deviation among cells dur-
ing the first minutes after APC contact, was followed by
a gradual rise in calcium to a plateau by 3.5–4.0 min after
contact (Figure S9). Two independent DE1 lines exhibited
the same overall profile of calcium flux, suggesting a TCR-
intrinsic phenotype rather than a TCR-independent phe-
notype resulting from long-term in vitro culture. These
data illustrate that the Ca DE loop is important for normal
TCR signal transduction in response to agonist ligands.
The control and DE1 lines did proliferate in response to
the agonist ligand (Figure S10). The DE1 lines proliferated
slightly more than the controls, but it was difficult to deter-
mine whether these differences were significant or within
Immunity
TCR-CD3 Interactions at the Ca DE and Cb CC0 Loopsthe normal range observed with outgrown lines. Blockade
of the CD4 coreceptor diminished proliferation of both the
control and DE1 lines (not shown).
The DE Loop Mutations Modulate Thymocyte
Responses
The abilities of the control, DE1, and DE2 mutant TCRs to
mediate thymocyte responses to peptides with a range of
affinities, which elicit a broad range of activity from 2B4 T
cells, were also evaluated. Agonist (MCC), weak agonist
(T102S), antagonist (T102G), or nonstimulatory (HB) pep-
tides were tested (Krogsgaard et al., 2003).
CD4CD8 thymocytes derived from 2B4b transgenic
(Tg) mice (Berg et al., 1989) bearing the Rag2/ mutation
(Shinkai et al., 1992) were transduced with retroviral vec-
tors encoding control, DE1, or DE2 TCRa subunits to re-
constitute expression of the full 2B4 TCR-CD3 complex.
Equivalent expression was achieved between the different
TCRs (Figure S11), indicating that the full complex is ex-
pressed on the surface of these cells. Indeed, CD3z was
present at the membrane at equivalent levels with respect
to TCRa in all three cell types (Figure S12).
CD69 and annexin V upregulation were analyzed on
TCR+ cells in response to TCR engagement. The data for
the mean percent CD69+ and annexin V+ cells in each of
four experiments was normalized to the mean value of
the respective experimental control and summarized as
a percent of the control (Figures 5A and 5B). CD69 and
annexin V levels were assessed on TCR thymocytes
cocultured with APC+HB peptide to insure that the re-
sponses were TCR dependent and to determine whether
Figure 4. The DE1 Mutation Alters T Cell Signaling to Agonist
pMHC
D10 lines expressing control or DE1 TCRs were cocultured with MCC
peptide-pulsed CH27 B cells. T cell/APC interactions were monitored
as described in Experimental Procedures. The x axis is in minutes. The
y axis represents the change in the 340 nm/380 nm Fura-2AM ratio
normalized to the precontact ratio. Ensemble averages ± standard
error are shown for cells from two individually derived lines for each
TCR (aWT Line 1 n = 15, Line 2 n = 13; aWT0 Line 1 n = 18, Line 2
n = 13; DE1 Line 1 n = 29, line 2 n = 12).responses within the HB sample by TCR+ cells were
TCR dependent. No significant differences were observed
between the TCR-negative cells in the control, DE1, or
DE2 samples, but higher responses were consistently
observed to the HB peptide for TCR+ cells compared to
TCR cells (Figure S13). This TCR-dependent response
could be to HB/I-Ek or endogenous pMHC complexes.
The latter is more likely because, when tested, no differ-
ences were seen between APC without peptide or with
the HB peptide (data not shown).
For the TCR+ cells that upregulated CD69, the DE loop
mutant cells generally exhibited a reduced response com-
pared with the controls (Figure 5A and Figure S13). Analy-
sis of variance (ANOVA) of the nonnormalized mean
values, for all stimuli and across all experiments, indicated
that the small differences between the control and DE1
TCRs were not significant. The larger differences between
the control and DE2 cells were significant (p < 0.05).
In contrast to CD69, the percent of DE loop mutant cells
expressing annexin V was generally higher compared with
the control cells for both mutants. The DE2 mutations also
had a greater impact on annexin V expression than the
DE1 mutations (Figure 5B and Figure S13). The differ-
ences between the control and DE1 cells were not signif-
icant by ANOVA with this sample size, but the differences
between the control and DE2 cells were (p < 0.01).
Paired t tests were performed on the nonnormalized
mean CD69 and annexin V values to determine whether,
in isolation, the DE1 and/or DE2 responses to individual
stimuli were significantly different than the controls. The
individual CD69 responses of the DE1 or DE2 cells did
not differ significantly from the controls. However, for an-
nexin V, the DE1 cell responses to HB and T102G and the
DE2 cell responses to T102S and T102Gwere significantly
different. Neither of themutant responses toMCC differed
significantly from the control cells.
The MAP kinase pathway is critical for the developmen-
tal program of thymocytes, and deletion of the ERK1 and 2
kinases results in a lack of positive selection (Fischer et al.,
2005). We also investigated whether the DE loop mutants
have reduced ERK1 and 2 phosphorylation in response to
TCR stimulus. Mutating the DE loop did result in a reduced
phospho-ERK 1 and 2 response across all stimulus com-
pared with the control (Figure 5C and Figure S14). Again,
the DE2 mutations had a greater impact than the DE1 mu-
tations, as indicated by the fact that the trend observed
for the DE1 mutant across all stimuli was not significant
by ANOVA for this sample size, whereas the reduced
DE2 response across all stimuli was highly significant
(p < 0.001). Paired t tests of the nonnormalized data for
the individual stimuli indicated that the differences be-
tween the control and DE2 responses were most signifi-
cant in response to the weakest stimuli. Even responses
to the non-peptide-pulsed APC were significantly lower
in the DE2 mutants compared with the controls. This sug-
gests a difference in responsiveness to the repertoire of
endogenous peptides presented by the APC. Overall,
the thymocyte data indicate that the DE loop is involved
in TCR signaling.Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc. 363
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How information is transferred from the TCRpMHC inter-
face to the intracellular signaling machinery is poorly un-
derstood (Kuhns et al., 2006). The extracellular regions
of the TCR-CD3 complex are likely to be involved in this
process, making their spatial organization and intersubu-
nit contacts key to the earliest events in TCR signaling.
In this study we show that: (1) the adjacent Ca DE and
Cb CC0 loops of the abTCR interact with CD3d3 and
CD3g3, respectively; (2) TCR-CD3d3 interactions stabilize
CD3g3 in the TCR-CD3 complex; and (3) disrupting these
contacts causes subtle but significant changes in T cell
and thymocyte responses to pMHC.
As with all mutagenesis studies, one caveat is that the
mutations studied here may cause unintentional confor-
mational changes at a distant site in the TCR. Several lines
of evidence suggest that the phenotypes of these muta-
tions are intrinsic to the targeted loops. The Ca DE and
Cb CC0 loops are contained within their respective con-
stant domain immunoglobulin (Ig) folds. Ig folds are cate-
gorized into six main subtypes based upon similarities of
the hydrophobic core that stabilize the member proteins
(Halaby et al., 1999). Comparisons of loop sequences
within and between subtype members have not revealed
any conserved residues that are critical to the stability of
the Ig domains (Bork et al., 1994; Halaby et al., 1999). In-
deed, diverse loop lengths and sequences can protrude
from the antiparallel b sheets of Ig folds, and a number of
receptors take advantage of the stability of the core fold,
and flexibility in the interstrand loops, to interact with their
ligands. For example, TCRs and antibodies use their CDR
loops to bind ligands, but there is no structural evidence
that sequence variability or flexibility in these loops results
in changes in other parts of the molecule.
The data presented here allow us to propose a general
arrangement of the extracellular domains of the TCR and
CD3 heterodimers (Figure 6A). They indicate that CD3d3
and CD3g3 contact the TCR next to one another at the
juncture between the Ca and Cb domains near the a hinge
(Figures 6A and 6B). The open face arrangement is consis-
tent, for CD3g3, with previous findings that TCRb and
CD33 interact through their extracellular domains (Mano-
lios et al., 1994) and that TCRb and CD3g are close
enough to be chemically crosslinked (Brenner et al.,
1985; Koning et al., 1990). This model also places the
CD33 subunit of CD3g3 in a pocket previously identified
by modeling as a possible docking site (Sun et al.,
2001). Interestingly, the Cb FG loop borders this area on
one side. Thus, CD3g3 docking in this pocket is consistentwith the recent finding that deletion of the Cb FG loop de-
stabilizes the TCR-CD3 complex (Touma et al., 2006).
The CD3 heterodimers are situated in Figure 6A such
that CD3d and CD3g could contact each other when
docked onto a TCR. This accounts for our findings that
TCR-CD3g3 interactions are stabilized by TCR-CD3d3 in-
teractions as well as the Cb CC0 loop and for the observa-
tion that optimal TCR-CD3g3 interactions require the pres-
ence of CD3d3 (Call et al., 2002). TCR-CD3d3 interactions
could contribute to CD3g3 stability within the complex by
forming a composite surface that constitutes part of the
CD3g3 docking site and/or through inducing a change in
some of the loops of the Cb domain to enhance the affinity
of TCR-CD3g3 interactions.
Numerous scenarios can be envisioned for how infor-
mation is transferred from the TCRpMHC interface to the
intracellular signaling machinery (Kuhns et al., 2006). The
data presented here indicate that extracellular contacts
between the TCR and CD3 heterodimers that stabilize
the complex are also important for signaling. Thus, the ex-
tracellular domains of the complex subunits might move
as a unit upon TCR engagement. But what force would in-
duce this movement? Soluble class II pMHC dimers can
trigger TCR signaling in a CD4-dependent manner (Krogs-
gaard et al., 2005). Thus, the TCR, CD3, CD4, and pMHC
molecules represent the base components of a minimal
activation complex for CD4+ T cells. When a class II
pMHC is bound by a TCR and a CD4 molecule, a V-
shaped structure is likely to form to accommodate the
size of the various molecules (Wang et al., 2001). Interest-
ingly, in the known cocomplexes, the TCR Va and Vb do-
mains dock onto the pMHC in the same general orienta-
tion (Rudolph et al., 2006), so the Ca DE and Cb CC0
loops will always be positioned on the same face of a
TCRpMHC unit as the binding sites of the CD4 or CD8 cor-
eceptors (Figure 6B; Gao et al., 1997; Wang et al., 2001).
Within the V-shaped structure, the CD3 heterodimers
would sit inside the angle between the TCR and the mem-
brane like a wedge at the base of a lever (Figure 6C). If the
angle of the TCR with respect to the membrane is larger
for an unbound versus bound TCR, then engagement of
a pMHC held in place by CD4might displace the CD3 het-
erodimers into the membrane. Or, the TCR may pivot
slightly over the top of the CD3 wedge, if the weak extra-
cellular contacts allow some change in the conformation
of the subunits with respect to each other. In addition,
any torque that is generated through conformational
changes in the CDRs at the TCRpMHC interface to be di-
rectionally transmitted through the TCR (Krogsgaard et al.,
2003). These possibilities are not mutually exclusive, andFigure 5. The DE Loop Mutations Alter Antigen-Specific CD69, Annexin V, and Phospho-Erk1 and 2 Responses in Thymocytes
(A) The DE2 mutation decreases CD69 responses. CD4CD8 thymocytes from 2B4bTg/Rag2/ mice were transduced with control, DE1, or DE2
mutant TCRa constructs, cocultured with peptides and APC for 5 hr, and analyzed as described in Experimental Procedures. The mean of triplicates
were normalized to the control cell mean values for each peptide condition. Each data point represents the normalized values for an individual
experiment. Red and yellow bars represent the p values of paired t tests for control versus DE1 or DE2 cells, respectively.
(B) The DE1 and DE2 mutations increase Annexin V responses to weak antigens. Analysis was performed on the same thymocytes used in (A).
(C) The DE2 mutation decreases ERK1 and 2 phosphorylation. Thymocytes were prepared as in (A), but cocultured with APCs for 15 min.
(A) and (B) are composites of four experiments and (C) is a composite of three experiments.Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc. 365
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TCR-CD3 Interactions at the Ca DE and Cb CC0 LoopsFigure 6. Models of TCR-CD3 Complex Orientation and Triggering
(A) Proposed orientation of the TCR and CD3 heterodimer extracellular domains. Cartoon structures of the mouse 2C TCR (Garcia et al., 1996), col-
ored as in Figure 2A, are shownwith sheep/mouseCD3d3 (yellow/red) (Sun et al., 2004) andmouse CD3g3 (green/red) (Sun et al., 2001). The bottom of
the complex, looking out from a T cell, is shown. The space-filled residues highlight asparagines that are part of a consensus NXT/S N-linked glyco-
sylation site. The salmon-colored residue on CD3 delta indicate the approximate location of a site on the mouse protein that is not conserved in the
sheep structure shown. The Cb FG loop is indicated by an asterisk.
(B) The CD3 and CD4 binding sites are on the same face of a TCRpMHC unit. A cartoon model of the TCR is shown bound to class II pMHC (a chain in
yellow, b chain in salmon, and peptide in green). The CaDE loop (cyan) and CbCC0 loop (orange) as well as the general region of CD4 contact to MHC
(red) (Wang et al., 2001) are shown as spheres. TCRpMHC was generated by superimposing the 2C TCR on the D10 fvTCR/I-Ak structure (Reinherz
et al., 1999).
(C) Model of TCR-CD3 triggering. When a T cell (top) comes in contact with an APC (bottom), TCRs scan pMHC for agonist ligands. Concomitant
binding of CD4 and TCRs to an agonist pMHC forms a V-like structure that forces a change in the orientation of the TCR-CD3 complex with respect
to the membrane.all provide reasonable scenarios for how a force could be
generated and transmitted across the cell membrane.
The vertical dispositions of the extracellular regions of
the TCR and CD3 heterodimers are pertinent to this dis-
cussion. The lengths of the TCR-connecting peptides
are longer (19–26 aa) than those of the CD3 heterodimers
(5–10 aa) (Sun et al., 2004). Thus, the CD3 heterodimers
might sit below the TCR as the complex protrudes from
the membrane. Alternatively, the long TCR-connecting
peptidesmay be needed to cover the distance from the in-
terchain disulfide bound to the tethers of the CD3 hetero-
dimers to facilitate the charge-mediated helix bundling of
the transmembrane domains (Sun et al., 2004). This would
place the TCR and CD3 heterodimers roughly equidistant
from the membrane. The location of the DE and CC0 loops
at the top of the respective Ca and Cb domains suggest
that, even if these regions contact only the tops of the
CD3 heterodimers, a small vertical displacement would
occur between the Ca, Cb, and CD3 Ig domains. This
may support a more rigid, unified movement of the com-
plex, but a slight pivot resulting from weak contacts can-
not be excluded. In either case, a change in the conforma-
tion of the TCR with respect to the membrane is a likely
step in TCR signaling.
In closing, the roles of the Ca DE and Cb CC0 loops in
complex stability are likely to be similar between mouse
andman. The DE loop is highly conserved among rodents,
cats, dogs, and humans, while the CC0 loop is absolutely
conserved between mouse and man. Refining our under-366 Immunity 26, 357–369, March 2007 ª2007 Elsevier Inc.standing of the structural organization and function of this
T cell signaling complex is important, because it is central
to the initiation of T cell responses against foreign and self
antigens. It is also critical for understanding the mecha-
nism of action by which humanized monoclonal anti-
bodies directed against the TCR-CD3 complex function
in the prevention of transplant rejection and, potentially,
autoimmune disease (Chatenoud, 2005), as well as in
the design of therapeutics directed against this complex.
EXPERIMENTAL PROCEDURES
Constructs
2B4 TCR cDNAs were amplified by RT-PCR from transgenic 2B4
lymph node cells (Berg et al., 1989) and cloned into pUC18 (Fermen-
tas). Unique restriction enzyme sites were introduced into the constant
region genes by PCR-based site-directed mutagenesis. Annealed
complementary synthetic oligonucleotides encoding the desired mu-
tations were cloned into the appropriate sites. The TCRa and TCRb
genes were subcloned into the retroviral expression vectors pZ4-
MSCV(IRES-zeocin resistance) and pP2mEGFP-MSCV(IRES-puro-
mycin resistance), respectively. The base vectors were a gift from W.
Sha. mEGFP was generated from EGFP (Zacharias et al., 2002).
CD3dg3z-2A WT pMIGII was a kind gift from D. Vignali (Szymczak
et al., 2004). The sequences of all oligonucleotides (Proligo) can be
obtained upon request.
Cell Lines and Peptides
The B cell lymphomas, M12 and Ch27, and the CD4+ T cell line, D10,
were grown in RPMI 1640 with 10% FCS (HyClone), L-glutamine Pen-
Strep solution (Gemini), and 50 mM 2-mercaptoethanol. D10 cells
Immunity
TCR-CD3 Interactions at the Ca DE and Cb CC0 Loops(ATCC) were maintained by weekly stimulations with irradiated (1500
rads) splenocytes from B10.BR mice and 200 mg/ml conalbumin
(Sigma). 50 u/ml rmIL-2 (R&D Systems) was added at 24 hr after stim-
ulation for the duration of the weekly cycle. The retroviral packaging
line Phoenix E (ecotropic) was maintained in DMEM with 10% FCS
and L-glutamine Pen-Strep solution. MCC 88-103 (ANERADLIAYLKQ
ATK), the altered peptides T102S and T102G, and HB 64-76 (GKKVIT
AFNEGLK) (BioSynthesis) were purified by reverse phase HPLC.
Retroviral Transduction
Phoenix E cells were transiently transfected with TCR or CD3 con-
structs with Fugene 6 (Roche) according to themanufacturer’s instruc-
tions. Supernatant was harvested at 48 and 72 hr after transfection and
concentrated to 0.5 ml in a 100 kDa Amicon Ultra centrifugation filter
(Millipore). 2 3 106 target cells were plated in 2 ml of growth media,
including the viral supernatant and 8 mg polybrene (Sigma), and centri-
fuged for 2 hr at 32C/1500 3 g prior to culturing at 37C. Puromycin
(BD) and Zeocin (Invitrogen) were applied 24 hr later at concentrations
determined for each cell line.
Flow Cytometry and Analysis
Samples were stained on ice in HBSS+2% FCS, 0.05% sodium azide.
20 mg/ml mAb 2.4G2 was added to block FcgIII/IIR for 30 min prior to
staining with analytical mAbs. Anti-Va11, Vb3, TCRb (H57), CD33
(2C11), CD4, CD69 and H2-Kd, or annexin V (BD Pharmingen) were
used as indicated in the figures, tables, or text. Pretreatment with
10 mg/ml H57 was performed, when indicated, for 30 min prior to
additional mAbs. Data were collected on a Beckman-Coulter FC500
and analyzed with FlowJo software (Treestar). Live gates were set by
forward and side-scatter. Analysis for TCR-CD3 expression on M12
cells was performed on mEGFPhi cells.
For ERK staining, cells were fixed in 2%PFA for 30min at room tem-
perature, permeabilized in 90% methanol at 4C for 1 hr, and subse-
quently stained for 30 min with anti-phospho-ERK1 and 2 (Cell Signal-
ing) and biotinylated anti-Va11. Cells were then washed and stained
with Cy2 donkey anti-rabbit (Jackson IR), cychrome streptavidin,
and PE-conjugated anti-Vb3 (BD Pharmingen) for 30 min. Analysis
was performed on TCR+ or TCR cells as indicated in the figures.
CD69 and annexin V gates were set to include less than 2.0% of the
control/HB TCR populations. The phospho-ERK1 and 2 were set to
include less than 0.2% of the control/no-peptide TCR populations.
Surface Immunoprecipitation and Western Blots
All steps were performed on ice. Cells were washed with ice-cold
HBSS/2%FCS/0.05% sodium azide, treated with 20 mg/ml mAb 2.4G2
for 30 min, and, if needed, subsequently treated with H57 for 30 min.
Finally, 5 mg of biotinylated anti-Va11, CD33 (2C11), or H2-Kd were
added for 30 min. Samples were washed 33 in wash buffer, 13 in
TBS (pH 8.0), and resuspended in 1 ml lysis buffer: TBS (pH 8.0)/1%
IGEPAL-CA630 (Sigma)/13 Complete protease inhibitors (Roche).
2 3 106 anti-mouse CD8 DynaBeads (Dynal) were added for 20 min.
Beads were removed by magnet, and 53 107 streptavidin-conjugated
DynaBeads were added to the supernatant for 30min. The beads were
washed 43 in lysis buffer by magnet extraction and boiled in SDS-
PAGE reducing buffer. The samples were resolved by 10% SDS-
PAGE. Blots were probed simultaneously with 1:150 goat anti-CD3d
(M-20) and 1:100 anti-CD3g (W-12) (Santa Cruz), then with 1:10,000
donkey anti-goat conjugated with HRP (Jackson IR) after washing.
The specificity of the anti-CD3g and anti-CD3d were verified with
lysates from 293T cells stably transfected with constructs expressing
either CD3g, d, 3, or z (generous gift of B. Lillemeier). HRP signal was
detected with SuperSignal West Pico Chemilluminescence (Pierce)
and Hyperfilm ECL (Amersham). To detect TCRbmEGFP, blots were
reprobedwith 1:100 rabbit anti-GFP (gift of B. Lillemeier and J. Huppa),
then 1:5000 donkey anti-rabbit-HRP (Amersham), and detected as
above. Quantitation of band intensity was performed with ImageJ soft-
ware (http://rsb.info.nih.gov/ij/).Microscopy and Analysis
For the calcium flux experiments, CH27 cells were pulsed overnight
with 5 mM purified MCC peptide. D10 cells were harvested on day 8
after restimulation and loaded with 7.5 mg/ml Fura-2AM (Molecular
Probes) for 30 min at room temperature. D10 and CH27 cells were
mixed 1:1 and imaged by live video microscopy techniques as previ-
ously described (Irvine et al., 2002). Fura ratio measurements were
analyzed with the MetaMorph software suite.
Thymocyte CD69, Annexin V, and Phospho-ERK1/2 Expression
2B4bTg mice were crossed with B10.A.Rag2/ mice (Taconic) and
screened by PCR and flow cytometry. Mice were housed at Stanford
University and used with approval of the Stanford University Commit-
tee on Animal Welfare. Thymi from 4- to 6-week-old mice were disso-
ciated, and CD4+, CD8+, and CD4+8+ cells were removed with anti-
CD4 and CD8 Dynal beads (Dynal) according to the manufacturer’s
instructions. CD4CD8 cells were retrovirally transduced with con-
structs encoding the WT0, DE1, and DE2 TCRa and cultured in the
presence of 5 ng/ml rIL-7 (R&D systems) for 24 hr.
For CD69 and annexin V expression, the cells were then cocultured
with HB, MCC, T102S, or T102G peptide and CH27 B cells for 5 hr at
37C prior to being washed, stained, and analyzed by flow cytometry.
For phospho-ERK1 and 2 analysis, CH27 cells were pulsed overnight
with MCC, T102S, T102G, or no peptide prior to coculture with thymo-
cytes for 15 min at 37C. Cells were immediately pelleted, washed in
ice-cold 2 mM EDTA/HBS (pH 7.4) to disrupt couples prior to fixation
and staining. Normalized values were determined by dividing the per-
cent CD69+, annexin V+, or phospho-ERK1 and 2+ values for the DE1
and DE2 cells by the mean control cell value for each stimulus condi-
tion. Two-way ANOVA analysis was performed with the MiniTab soft-
ware. Two-tailed paired t tests were performed in Microsoft Excel. All
statistical tests were performed with the nonnormalized mean values.
Supplemental Data
Supplemental Data include 14 figures and 1 table and can be found
with this article online at http://www.immunity.com/cgi/content/full/
26/3/357/DC1/.
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